FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paolo Gionchetti

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Procedures

Concepts & Ideas

Treatment Outcome

Anatomy

Co-author Network

Publications

TOP 3
Gert Van Assche; Laurent Beaugerie; Bernd Bokemeyer; Silvio Danese; Axel Dignass; Paolo Gionchetti; Fernando Gomollón; Winfried Häuser; Klaus Herrlinger; Gabriele Moser; Bas Oldenburg; Julian Panes; Francisco Portela; Gerhard Rogler; Jürgen Stein; Herbert Tilg; Simon Travis; James O Lindsay
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
A Agostini; Francesca Benuzzi; A Bertani; Carlo Calabrese; Massimo Campieri; Mauro Ercolani; V Farinelli; N Filippini; Paolo Gionchetti; C Marchetta; Fernando Rizzello; A Scarcelli; Paolo Nichelli
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study.
Paolo Gionchetti; Silvio Laureti; Gilberto Poggioli; C Pratico; A Calafiore; Massimo Campieri; G Vitali; Fernando Rizzello
Randomized controlled trials in pouchitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paolo Gionchetti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gert Van Assche; Laurent Beaugerie; Bernd Bokemeyer; Silvio Danese; Axel Dignass; Paolo Gionchetti; Fernando Gomollón; Winfried Häuser; Klaus Herrlinger; Gabriele Moser; Bas Oldenburg; Julian Panes; Francisco Portela; Gerhard Rogler; Jürgen Stein; Herbert Tilg; Simon Travis; James O Lindsay
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
Journal of Crohn's & colitis 2013;7(1):1-33.
2013: A Agostini; Francesca Benuzzi; A Bertani; Carlo Calabrese; Massimo Campieri; Mauro Ercolani; V Farinelli; N Filippini; Paolo Gionchetti; C Marchetta; Fernando Rizzello; A Scarcelli; Paolo Nichelli
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2013;25(2):147-e82.
2012: Paolo Gionchetti; Silvio Laureti; Gilberto Poggioli; C Pratico; A Calafiore; Massimo Campieri; G Vitali; Fernando Rizzello
Randomized controlled trials in pouchitis.
Reviews on recent clinical trials 2012;7(4):303-6.
2012: Cosimo Prantera; ML Scribano; Silvio Danese; Paolo Gionchetti; Maria Grimaldi; Herbert Lochs
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease.
Gastroenterology 2012;142(3):473-481.e4.
2011: Carlo Calabrese; Massimo Campieri; Massimo Derenzini; Paolo Gionchetti; Giuseppina Liguori; Lorenzo Montanaro; Fernando Rizzello; Elisa Brighenti; Manuela Vici; Davide Trerè
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease.
World journal of gastroenterology : WJG 2011;17(40):4496-502.
2011: Carlo Calabrese; Massimo Campieri; S Di Molfetta; Paolo Gionchetti; G Lazzarini; G Liguori; V Marzano; Fernando Rizzello; A Urbani; M C Valerii; Enzo Spisni
Distinct proteomic profiles characterise non-erosive from erosive reflux disease.
Alimentary pharmacology & therapeutics 2011;34(8):982-93.
2011: Aurora Bortoli; F Castiglione; A Corbellini; Renata D'inca; D Duricova; Paolo Gionchetti; J P Gisbert; M Marrollo; P Munkholm; M R Panelli; N Pedersen; G Riegler; A L Sanroman; S Segato; Daniela Valpiani; S Ardizzone; I Arena
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006.
Alimentary pharmacology & therapeutics 2011;34(7):724-34.
2011: Alessandro Agostini; Carlo Calabrese; Raffaele Agati; Daniela Cevolani; Mauro Ercolani; Nicola Filippini; Paolo Gionchetti; Marco Leonardi; Chiara Leoni; Fernando Rizzello; Rosy Tambasco; Massimo Campieri
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing.
Inflammatory bowel diseases 2011;17(8):1769-77.
2011: Carlo Calabrese; Paolo Gionchetti; Giuseppina Liguori; Alessandra Areni; Giulia Spuri Fornarini; Massimo Campieri; Fernando Rizzello
Clinical course of microscopic colitis in a single-center cohort study.
Journal of Crohn's & colitis 2011;5(3):218-21.
2011: Paolo Gionchetti; Carlo Calabrese; Rosy Tambasco; Ramona Brugnera; Giulia Straforini; Giuseppina Liguori; Giulia Spuri Fornarini; Donatella Riso; Massimo Campieri; Fernando Rizzello
Role of conventional therapies in the era of biological treatment in Crohn's disease.
World journal of gastroenterology : WJG 2011;17(14):1797-806.
2011: Mario Cottone; Anna Kohn; Marco Daperno; Alessandro Armuzzi; Luisa Guidi; Renata D'inca; Fabrizio Bossa; Erika Angelucci; Livia Biancone; Paolo Gionchetti; Sandro Ardizzone; Claudio Papi; Walter Fries; Silvio Danese; Gabriele Riegler; Maria Cappello; Fabiana Castiglione; Vito Annese; Ambrogio Orlando
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(1):30-5.
2011: Ambrogio Orlando; Alessandro Armuzzi; Claudio Papi; Vito Annese; Sandro Ardizzone; Livia Biancone; Aurora Bortoli; Fabiana Castiglione; Renata D'Incà; Paolo Gionchetti; Anna Kohn; Gilberto Poggioli; Fernando Rizzello; Maurizio Vecchi; Mario Cottone
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(1):1-20.
2010: Carlo Calabrese; Enzo Spisni; G Liguori; G Lazzarini; M C Valerii; Antonio Strillacci; Paolo Gionchetti; Uberto Pagotto; Massimo Campieri; Fernando Rizzello
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 2010;32(4):603-11.
2010: Milan Lukas; Pavel Drastich; Michal Konecny; Paolo Gionchetti; Ondrej Urban; Franco Cantoni; Martin Bortlik; Dana Duricova; Michael Bulitta
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis.
Inflammatory bowel diseases 2010;16(7):1180-6.
2010: Alessandro Agostini; Fernando Rizzello; Gianni Ravegnani; Paolo Gionchetti; Rosy Tambasco; Giulia Straforini; Mauro Ercolani; Massimo Campieri
Adult attachment and early parental experiences in patients with Crohn's disease.
Psychosomatics 2010;51(3):208-15.
2010: Silvia Turroni; Beatrice Vitali; Marco Candela; Paolo Gionchetti; Fernando Rizzello; Massimo Campieri; Patrizia Brigidi
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach.
World journal of gastroenterology : WJG 2010;16(1):30-41.
2010: Alessandro Agostini; Fernando Rizzello; Gianni Ravegnani; Paolo Gionchetti; Rosy Tambasco; Mauro Ercolani; Massimo Campieri
Parental bonding and inflammatory bowel disease.
Psychosomatics 2010;51(1):14-21.
2009: Magda Monari; J Foschi; Carlo Calabrese; G Liguori; Giulio Di Febo; Fernando Rizzello; Paolo Gionchetti; Andrea Trinchero; Gian Paolo Serrazanetti
Implications of antioxidant enzymes in human gastric neoplasms.
International journal of molecular medicine 2009;24(5):693-700.
2009: Darrell S Pardi; Geert D'Haens; Bo Shen; Simon Campbell; Paolo Gionchetti
Clinical guidelines for the management of pouchitis.
Inflammatory bowel diseases 2009;15(9):1424-31.
2009: Loris Pironi; Francesca Bonvicini; Paolo Gionchetti; Antonia D'Errico; Fernando Rizzello; Catia Corsini; Laura Foroni; Giorgio Gallinella
Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.
Journal of clinical microbiology 2009;47(5):1591-5.
2009: Beatrice Vitali; Federico Perna; Karen Lammers; Silvia Turroni; Paolo Gionchetti; Patrizia Brigidi
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis.
International journal of antimicrobial agents 2009;33(4):387-9.
2008: Paolo Gionchetti; Fernando Rizzello; Rosy Tambasco; G Straforini; Gilberto Poggioli; Carlo Calabrese; R Brugnera; Massimo Campieri
Which therapies are advisable in pouchitis?
Inflammatory bowel diseases 2008;14 Suppl 2():S241-2.
2008: Marco Candela; F Perna; P Carnevali; Beatrice Vitali; R Ciati; Paolo Gionchetti; Fernando Rizzello; Massimo Campieri; Patrizia Brigidi
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.
International journal of food microbiology 2008;125(3):286-92.
2008: Fernando Rizzello; Massimo Campieri; Rosy Tambasco; G Straforini; R Brugnera; G Poggioli; Paolo Gionchetti
Medical treatment and management of severe ulcerative colitis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2008;40 Suppl 2():S280-4.
2008: Carlo Calabrese; G Liguori; V Gabusi; Paolo Gionchetti; Fernando Rizzello; G Straforini; R Brugnera; Giulio Di Febo
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Alimentary pharmacology & therapeutics 2008;28(2):250-5.
2008: Carlo Calabrese; Paolo Gionchetti; Fernando Rizzello; G Liguori; V Gabusi; Rosy Tambasco; Gilberto Poggioli; Filippo Pierangeli; Massimo Campieri; Giulio Di Febo
Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.
Alimentary pharmacology & therapeutics 2008;27(9):759-64.
2008: Livia Biancone; Axel Dignass; Johanna C Escher; Alastair Forbes; Paolo Gionchetti; Jörg C Hoffmann; Günter Jantschek; Ralf Kiesslich; Sanja Kolacek; Pierre Michetti; Rod Mitchell; Gabriele Moser; Julian Panes; Johan Soderholm; Eduard Stange; Simon Travis; Boris Vucelic
European evidence-based Consensus on the management of ulcerative colitis: Special situations.
Journal of Crohn's & colitis 2008;2(1):63-92.
2007: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Gilberto Poggioli; Rosy Tambasco; Carlo Calabrese; Patrizia Brigidi; Beatrice Vitali; Giulia Straforini; Massimo Campieri
High-dose probiotics for the treatment of active pouchitis.
Diseases of the colon and rectum 2007;50(12):2075-82; discussion 2082-4.
2007: Mauro D'Amato; Sara Bruce; Francesca Bresso; Marco Zucchelli; Sini Ezer; Ville Pulkkinen; Cecilia Lindgren; Marco Astegiano; Mario Rizzetto; Paolo Gionchetti; Gabriele Riegler; Raffaello Sostegni; Marco Daperno; Sandra D'Alfonso; Patricia Momigliano-Richiardi; Leif Torkvist; Pauli Puolakkainen; Maija Lappalainen; Paulina Paavola-Sakki; Leena Halme; Martti Farkkila; Ulla Turunen; Kimmo Kontula; Robert Lofberg; Sven Pettersson; Juha Kere
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.
Gastroenterology 2007;133(3):808-17.
2007: Simona Maule; Giulia Pierangeli; Sabina Cevoli; Daniela Grimaldi; Paolo Gionchetti; Giovanni Barbara; Fernando Rizzello; Vincenzo Stanghellini; Roberto Corinaldesi; Massimo Campieri; Pietro Cortelli
Sympathetic hyperactivity in patients with ulcerative colitis.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2007;17(4):217-20.
2007: Gilberto Poggioli; Silvio Laureti; Massimo Campieri; Filippo Pierangeli; Paolo Gionchetti; Federica Ugolini; Lorenzo Gentilini; Piero Bazzi; Fernando Rizzello; Maurizio Coscia
Infliximab in the treatment of Crohn's disease.
Therapeutics and clinical risk management 2007;3(2):301-8.
2007: Carlo Calabrese; Anna Fabbri; Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; G Liguori; Gilberto Poggioli; Massimo Campieri; Giulio Di Febo
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis.
Alimentary pharmacology & therapeutics 2007;25(11):1311-6.
2007: Paolo Gionchetti; Fernando Rizzello; Gilberto Poggioli; Filippo Pierangeli; Silvio Laureti; Claudia Morselli; Rosy Tambasco; Carlo Calabrese; Massimo Campieri
Oral budesonide in the treatment of chronic refractory pouchitis.
Alimentary pharmacology & therapeutics 2007;25(10):1231-6.
2007: Francesca Bresso; Johan Askling; Marco Astegiano; Brunello Demarchi; Nicoletta Sapone; Mario Rizzetto; Paolo Gionchetti; Karen Lammers; Annalisa de Leone; Gabriele Riegler; Elaine R Nimmo; Hazel E Drummond; Colin L Noble; Leif Torkvist; Anders Ekbom; Marco Zucchelli; Robert Lofberg; Jack Satsangi; Sven Pettersson; Mauro D'Amato
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease.
Inflammatory bowel diseases 2007;13(5):531-6.
2007: Livia Biancone; Paolo Gionchetti; G Del Vecchio Blanco; Ambrogio Orlando; Vito Annese; Claudio Papi; Raffaello Sostegni; Renata D'Incà; Carmelina Petruzziello; Alessandro Casa; Giuseppe S Sica; Emma Calabrese; Massimo Campieri; Francesco Pallone
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2007;39(4):329-37.
2007: Carla Serra; Guido Menozzi; Antonio Maria Morselli Labate; Francesco Giangregorio; Paolo Gionchetti; Marina Beltrami; Daniela Robotti; Fabio Fornari; Teresa Cammarota
Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent.
European journal of radiology 2007;62(1):114-21.
2007: Beatrice Passarini; Salvatore Domenico Infusino; Elena Barbieri; Elisa Varotti; Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Rosy Tambasco; Massimo Campieri
Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Dermatology (Basel, Switzerland) 2007;215(4):295-300.
2006: Matteo Massi; Pierfranco Ioan; Roberta Budriesi; Alberto Chiarini; Beatrice Vitali; Karen Lammers; Paolo Gionchetti; Massimo Campieri; Anthony Lembo; Patrizia Brigidi
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue.
World journal of gastroenterology : WJG 2006;12(37):5987-94.
2006: Ulf Helwig; Karen Lammers; Fernando Rizzello; Patrizia Brigidi; Verena Rohleder; Elisabetta Caramelli; Paolo Gionchetti; Jürgen Schrezenmeir; Ulrich R Foelsch; Stefan Schreiber; Massimo Campieri
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.
World journal of gastroenterology : WJG 2006;12(37):5978-86.
2006: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Rosy Tambasco; Massimo Campieri
Review article: aminosalicylates for distal colitis.
Alimentary pharmacology & therapeutics 2006;24 Suppl 3():41-4.
2006: Rita Golfieri; A Cappelli; Emanuela Giampalma; Fernando Rizzello; Paolo Gionchetti; Silvio Laureti; Gilberto Poggioli; Massimo Campieri
CT-guided percutaneous pelvic abscess drainage in Crohn's disease.
Techniques in coloproctology 2006;10(2):99-105.
2006: Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Claudia Morselli; Lucia Sollazzi; Samuel Davies; Rosy Tambasco; Carlo Calabrese; Massimo Campieri
Antibiotics and probiotics in treatment of inflammatory bowel disease.
World journal of gastroenterology : WJG 2006;12(21):3306-13.
2006: Tanja Kühbacher; Stephan J Ott; Ulf Helwig; T Mimura; Fernando Rizzello; Brigitta Kleessen; Paolo Gionchetti; Michael Blaut; Massimo Campieri; Ulrich R Fölsch; M A Kamm; Stefan Schreiber
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.
Gut 2006;55(6):833-41.
2006: Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Claudia Morselli; Rosy Tambasco; Massimo Campieri
Antimicrobials in the management of inflammatory bowel disease.
Digestion 2006;73 Suppl 1():77-85.
2006: Gabriele Riegler; Luigi Caserta; Fabiana Castiglione; Ilaria Esposito; Daniela Valpiani; Vito Annese; G Zoli; Paolo Gionchetti; Angelo Viscido; Giacomo Carlo Sturniolo; Antonio Rispo; Francesca Romana De Filippo; Annalisa de Leone; R Carratu
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(1):18-23.
2005: Paolo Gionchetti; Karen Lammers; Fernando Rizzello; Massimo Campieri
VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.
Gastroenterology clinics of North America 2005;34(3):499-513, ix-x.
2005: Rodrigo Bibiloni; Richard N Fedorak; Gerald W Tannock; Karen L Madsen; Paolo Gionchetti; Massimo Campieri; Claudio De Simone; Ryan Sartor
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis.
The American journal of gastroenterology 2005;100(7):1539-46.
2005: Paolo Gionchetti; Karen Lammers; Fernando Rizzello; Massimo Campieri
Probiotics and barrier function in colitis.
Gut 2005;54(7):898-900.
2005: Paolo Gionchetti; Fernando Rizzello; Gilberto Poggioli; Claudia Morselli; Karen Lammers; Massimo Campieri
Probiotic therapy to prevent pouchitis onset.
Diseases of the colon and rectum 2005;48(7):1493; author reply 1493-4.
2005: Karen Lammers; Athanasios Vergopoulos; Nina Babel; Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Elisabetta Caramelli; Michelangelo Fiorentino; Antonia D'Errico; Hans-Dieter Volk; Massimo Campieri
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.
Inflammatory bowel diseases 2005;11(5):447-54.
2005: Alessandro Granito; Daniela Zauli; Paolo Muratori; Luigi Muratori; Alberto Grassi; Roberta Bortolotti; Nunzio Petrolini; Lorenza Veronesi; Paolo Gionchetti; Francesco B Bianchi; Umberto Volta
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
Alimentary pharmacology & therapeutics 2005;21(7):881-7.
2005: Gilberto Poggioli; Silvio Laureti; Filippo Pierangeli; Fernando Rizzello; Federica Ugolini; Paolo Gionchetti; Massimo Campieri
Local injection of Infliximab for the treatment of perianal Crohn's disease.
Diseases of the colon and rectum 2005;48(4):768-74.
2005: Paolo Gionchetti; Agesilao D'Arienzo; Fernando Rizzello; Francesco Manguso; Roberto Maieron; Pier Enrico Lecis; Daniela Valpiani; Gaetano Iaquinto; Vito Annese; Antonio Balzano; Guido Varoli; Massimo Campieri
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
Journal of clinical gastroenterology 2005;39(4):291-7.
2005: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Rossella Romagnoli; Massimo Campieri
Management of inflammatory bowel disease: does rifaximin offer any promise?
Chemotherapy 2005;51 Suppl 1():96-102.
2005: Vito Annese; Giovanni Lombardi; Francesco Perri; Renata D'Incà; Sandro Ardizzone; Gabriele Riegler; Stelio Giaccari; Maurizio Vecchi; Fabiana Castiglione; Paolo Gionchetti; Elena Cocchiara; Sergio Vigneri; Anna Latiano; Orazio Palmieri; Angelo Andriulli
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
The American journal of gastroenterology 2005;100(1):84-92.
2004: Ailsa L Hart; Karen Lammers; Patrizia Brigidi; Beatrice Vitali; Fernando Rizzello; Paolo Gionchetti; Massimo Campieri; Michael A Kamm; Stella C Knight; Andrew J Stagg
Modulation of human dendritic cell phenotype and function by probiotic bacteria.
Gut 2004;53(11):1602-9.
2004: Paolo Gionchetti; Claudia Morselli; Fernando Rizzello; Rossella Romagnoli; Massimo Campieri; Gilberto Poggioli; Silvio Laureti; Federica Ugolini; Filippo Pierangeli
Management of pouch dysfunction or pouchitis with an ileoanal pouch.
Best practice & research. Clinical gastroenterology 2004;18(5):993-1006.
2004: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Massimo Campieri
Review article: problematic proctitis and distal colitis.
Alimentary pharmacology & therapeutics 2004;20 Suppl 4():93-6.
2004: Ulf Helwig; Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Tanja Kühbacher; Stefan Schreiber; Marco Baggiolini; Mariagrazia Uguccioni; Massimo Campieri
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.
International journal of colorectal disease 2004;19(2):165-70.
2004: Vito Annese; Orazio Palmieri; Anna Latiano; Sandro Ardizzone; Fabiana Castiglione; Mario Cottone; Renata D'Incà; Paolo Gionchetti; Claudio Papi; Gabriele Riegler; Maurizio Vecchi; Angelo Andriulli
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(2):121-4.
2004: T Mimura; Fernando Rizzello; Ulf Helwig; Gilberto Poggioli; S Schreiber; I C Talbot; R J Nicholls; Paolo Gionchetti; Massimo Campieri; M A Kamm
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.
Gut 2004;53(1):108-14.
2003: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; Gilberto Poggioli; Massimo Campieri
Probiotics for the treatment of postoperative complications following intestinal surgery.
Best practice & research. Clinical gastroenterology 2003;17(5):821-31.
2003: Karen Lammers; Patrizia Brigidi; Beatrice Vitali; Paolo Gionchetti; Fernando Rizzello; Elisabetta Caramelli; Diego Matteuzzi; Massimo Campieri
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.
FEMS immunology and medical microbiology 2003;38(2):165-72.
2003: Massimo Campieri; S Adamo; Daniela Valpiani; Agesilao D'Arienzo; Giuseppe d'Albasio; M Pitzalis; P Cesari; Tino Casetti; Guido Castiglione; Fernando Rizzello; Francesco Manguso; Guido Varoli; Paolo Gionchetti
Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.
Alimentary pharmacology & therapeutics 2003;17(12):1471-80.
2003: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; Massimo Campieri
Review article: medical treatment of severe ulcerative colitis.
Alimentary pharmacology & therapeutics 2003;17 Suppl 2():7-10.
2003: Paolo Muratori; Luigi Muratori; Marcello Guidi; Silvana Maccariello; Georgios Pappas; Rodolfo Ferrari; Paolo Gionchetti; Massimo Campieri; Francesco B Bianchi
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
Clinical and experimental immunology 2003;132(3):473-6.
2003: Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Annamaria Venturi; Karen Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.
Gastroenterology 2003;124(5):1202-9.
2003: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; Gilberto Poggioli; Massimo Campieri
Diagnosis and treatment of pouchitis.
Best practice & research. Clinical gastroenterology 2003;17(1):75-87.
2003: Paolo Gionchetti; Fernando Rizzello; Flavio Habal; Claudia Morselli; Cristina Amadini; Rossella Romagnoli; Massimo Campieri
Standard treatment of ulcerative colitis.
Digestive diseases (Basel, Switzerland) 2003;21(2):157-67.
2003: Karen Lammers; G Innocenti; Annamaria Venturi; Fernando Rizzello; Ulf Helwig; Giampaolo Bianchi; L Pedrini; Gianfranco Di Nino; Paolo Gionchetti; Massimo Campieri
The effect of transient intestinal ischemia on inflammatory parameters.
International journal of colorectal disease 2003;18(1):78-85.
2002: Ignazio Olivieri; Angela Padula; Enrico Scarano; Paolo Gionchetti
Ileal pouchitis-related arthritis.
Seminars in arthritis and rheumatism 2002;32(3):204-5.
2002: Oren Shibolet; Fanny Karmeli; Rami Eliakim; Erwin Frans M. Swennen; Patrizia Brigidi; Paolo Gionchetti; Massimo Campieri; Sara Morgenstern; Daniel Rachmilewitz
Variable response to probiotics in two models of experimental colitis in rats.
Inflammatory bowel diseases 2002;8(6):399-406.
2002: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; V Palmonari; Claudia Morselli; Rossella Romagnoli; Massimo Campieri
Probiotics--role in inflammatory bowel disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2002;34 Suppl 2():S58-62.
2002: G Bazzocchi; Paolo Gionchetti; P F Almerigi; Cristina Amadini; Massimo Campieri
Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2002;34 Suppl 2():S48-53.
2002: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; Claudia Morselli; Massimo Campieri
Review article: the management of refractory Crohn's disease.
Alimentary pharmacology & therapeutics 2002;16 Suppl 4():40-7.
2002: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; Massimo Campieri
Review article: treatment of mild to moderate ulcerative colitis and pouchitis.
Alimentary pharmacology & therapeutics 2002;16 Suppl 4():13-9.
2002: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; Cristina Amadini; Rossella Romagnoli; Massimo Campieri
Review article: monitoring activity in ulcerative colitis.
Alimentary pharmacology & therapeutics 2002;16 Suppl 4():3-6.
2002: Fernando Rizzello; Paolo Gionchetti; Agesilao D'Arienzo; Francesco Manguso; Giovanni Di Matteo; Vito Annese; Daniela Valpiani; Tino Casetti; S Adamo; A Prada; Guido Castiglione; Guido Varoli; Massimo Campieri
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.
Alimentary pharmacology & therapeutics 2002;16(6):1109-16.
2002: Karen Lammers; Ulf Helwig; Erwin Frans M. Swennen; Fernando Rizzello; Annamaria Venturi; Elisabetta Caramelli; Michael A Kamm; Patrizia Brigidi; Paolo Gionchetti; Massimo Campieri
Effect of probiotic strains on interleukin 8 production by HT29/19A cells.
The American journal of gastroenterology 2002;97(5):1182-6.
2002: T Mimura; Fernando Rizzello; Ulf Helwig; Gilberto Poggioli; S Schreiber; I C Talbot; R J Nicholls; Paolo Gionchetti; Massimo Campieri; M A Kamm
Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.
Alimentary pharmacology & therapeutics 2002;16(5):909-17.
2002: Paolo Gionchetti; Fernando Rizzello; Massimo Campieri
Probiotics in gastroenterology.
Current opinion in gastroenterology 2002;18(2):235-9.
2001: Fernando Rizzello; Paolo Gionchetti; Roberta Galeazzi; G Novelli; Daniela Valpiani; Agesilao D'Arienzo; Francesco Manguso; Guido Castiglione; Guido Varoli; Massimo Campieri
Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study.
Advances in therapy 2001;18(6):261-71.
2001: Salvatore Ulisse; Paolo Gionchetti; S D'Alò; FP Russo; I Pesce; G Ricci; Fernando Rizzello; Ulf Helwig; Maria Grazia Cifone; Massimo Campieri; Claudio De Simone
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.
The American journal of gastroenterology 2001;96(9):2691-9.
2001: Paolo Gionchetti; Fernando Rizzello; Massimo Campieri
Probiotics and antibiotics in inflammatory bowel disease.
Current opinion in gastroenterology 2001;17(4):331-5.
2001: Tanja Kühbacher; Paolo Gionchetti; Jochen Hampe; Ulf Helwig; Philip Rosenstiel; Massimo Campieri; H J Buhr; Stefan Schreiber
Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis.
Clinical and experimental immunology 2001;123(3):395-401.
2001: Maurizio Vecchi; Gianmichele Meucci; Paolo Gionchetti; Marina Beltrami; P Di Maurizio ; L Beretta; E Ganio; P Usai; M Campieri; G Fornaciari; Roberto de Franchis
Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.
Alimentary pharmacology & therapeutics 2001;15(2):251-6.
2001: Massimo Campieri; Paolo Gionchetti
Bacteria as the cause of ulcerative colitis.
Gut 2001;48(1):132-5.
2000: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Patrizia Brigidi; Diego Matteuzzi; G Bazzocchi; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
Gastroenterology 2000;119(2):305-9.
2000: Ulf Helwig; Karen Lammers; Paolo Gionchetti; Fernando Rizzello; Massimo Campieri; Mariagrazia Uguccioni
MCP-3 in inflammatory bowel disease.
Gut 2000;47(1):155.
2000: Gilberto Poggioli; Silvio Laureti; L Stocchi; Massimo Campieri; Federica Ugolini; MariaCristina Salone; Paolo Gionchetti; O Lauriola; Fernando Rizzello
[Immediate and long-term results in ileoanastomosis with reservoir in 335 consecutive cases].
Chirurgia italiana 2000;52(3):215-22.
2000: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Massimo Campieri
Probiotics in infective diarrhoea and inflammatory bowel diseases.
Journal of gastroenterology and hepatology 2000;15(5):489-93.
1999: Annamaria Venturi; Paolo Gionchetti; Fernando Rizzello; R Johansson; E Zucconi; Patrizia Brigidi; Diego Matteuzzi; Massimo Campieri
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.
Alimentary pharmacology & therapeutics 1999;13(8):1103-8.
1999: Mariagrazia Uguccioni; Paolo Gionchetti; D F Robbiani; Fernando Rizzello; S Peruzzo; Massimo Campieri; Marco Baggiolini
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.
The American journal of pathology 1999;155(2):331-6.
1999: Paolo Gionchetti; Fernando Rizzello; A Ferrieri; Annamaria Venturi; C Brignola; M Ferretti; S Peruzzo; Mario Miglioli; Massimo Campieri
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.
Digestive diseases and sciences 1999;44(6):1220-1.
1999: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Federica Ugolini; M Rossi; Patrizia Brigidi; R Johansson; A Ferrieri; Gilberto Poggioli; Massimo Campieri
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
Alimentary pharmacology & therapeutics 1999;13(6):713-8.
1999: Paolo Gionchetti; Sandro Ardizzone; Michela Benvenuti; Gabriele Bianchi-Porro; Guido Biasco; P Cesari; Giuseppe d'Albasio; Roberto de Franchis; G Monteleone; F Pallone; T Ranzi; Giacomo Trallori; Daniela Valpiani; Maurizio Vecchi; Massimo Campieri
A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial.
Alimentary pharmacology & therapeutics 1999;13(3):381-8.
1999: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Federica Ugolini; M Rossi; Patrizia Brigidi; R Johansson; A Ferrieri; Gilberto Poggioli; Massimo Campieri
Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach.
European review for medical and pharmacological sciences 1999;3(1):27-30.
1998: Maurizio Vecchi; renato alberto sinico; MB Bianchi; Antonella Radice; Paolo Gionchetti; Massimo Campieri; Roberto de Franchis
Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance.
Scandinavian journal of gastroenterology 1998;33(12):1284-8.
1998: Massimo Campieri; Mario Cottone; F Miglio; F Manenti; Marco Astegiano; Agesilao D'Arienzo; Francesco Manguso; Giuseppe d'Albasio; Andrea G Bonanomi; Roberta Galeazzi; Ambrogio Orlando; Guido Castiglione; Paolo Gionchetti
Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis.
Alimentary pharmacology & therapeutics 1998;12(4):361-6.
1998: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; M Ferretti; S Peruzzo; X Raspanti; M Picard; N Canova; Ernesto Palazzini; Massimo Campieri
Rifaximin systemic absorption in patients with ulcerative colitis.
European journal of clinical pharmacology 1998;54(1):91-3.
1998: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; M Ferretti; C Brignola; Mario Miglioli; Massimo Campieri
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
Diseases of the colon and rectum 1998;41(1):93-7.
1997: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; C Brignola; M Ferretti; S Peruzzo; Massimo Campieri
Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
Alimentary pharmacology & therapeutics 1997;11(6):1053-7.
1997: M Ferretti; Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; P Stella; F Corti; J Mizrahi; Mario Miglioli; Massimo Campieri
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis.
Digestive diseases and sciences 1997;42(12):2606-11.
1997: Paolo Gionchetti; Annamaria Venturi; Fernando Rizzello; C Corbelli; Stefano Fanti; M Ferretti; Stefano Boschi; Mario Miglioli; Massimo Campieri
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis.
Alimentary pharmacology & therapeutics 1997;11(4):679-84.
1997: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; M Ferretti; C Brignola; S Peruzzo; C Belloli; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis.
Alimentary pharmacology & therapeutics 1997;11(4):673-8.
1997: Paolo Gionchetti; Maurizio Vecchi; Fernando Rizzello; M Ferretti; Carmen Calabresi; Annamaria Venturi; MB Bianchi; C Brignola; renato alberto sinico; Roberto de Franchis; Mario Miglioli; Massimo Campieri
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils.
Gut 1997;40(1):102-4.
1996: V Arienti; Massimo Campieri; L Boriani; Paolo Gionchetti; C Califano; S Giancane; A Furno; G Gasbarrini
Management of severe ulcerative colitis with the help of high resolution ultrasonography.
The American journal of gastroenterology 1996;91(10):2163-9.
1996: Paolo Gionchetti; Massimo Campieri; Annamaria Venturi; Fernando Rizzello; M Ferretti; C Brignola; Mario Miglioli
Systemic availability of 5-aminosalicylic acid: comparison of delayed release and an azo-bond preparation.
Alimentary pharmacology & therapeutics 1996;10(4):601-5.
1996: C Brignola; C Belloli; G De Simone; Massimo Campieri; Paolo Gionchetti; A Belluzzi
Analysis of biological variables in Crohn's disease.
Gut 1996;38(6):938-9.
1996: Massimo Campieri; A Belluzzi; Paolo Gionchetti; C Brignola; M Ferretti; F Rizello; E Bertinelli; Mario Miglioli; L Barbara
[Treatment of active ulcerative colitis].
Gastroenterología y hepatología 1996;19(1):24-6.
1994: A Belluzzi; C Brignola; Massimo Campieri; E P Camporesi; Paolo Gionchetti; Fernando Rizzello; C Belloli; G De Simone; S Boschi; Mario Miglioli
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients.
Digestive diseases and sciences 1994;39(12):2589-94.
1994: Paolo Gionchetti; Massimo Campieri; A Belluzzi; S Boschi; C Brignola; Mario Miglioli; L Barbara
Bioavailability of single and multiple doses of a new oral formulation of 5-ASA in patients with inflammatory bowel disease and healthy volunteers.
Alimentary pharmacology & therapeutics 1994;8(5):535-40.
1994: Maurizio Vecchi; Paolo Gionchetti; MB Bianchi; A Belluzzi; G Meucci; Massimo Campieri; Roberto de Franchis
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis.
Lancet 1994;344(8926):886-7.
1994: C Brignola; G De Simone; C Belloli; P Iannone; A Belluzzi; Paolo Gionchetti; Massimo Campieri; L Barbara
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration.
Alimentary pharmacology & therapeutics 1994;8(4):465-8.
1994: Paolo Gionchetti; Massimo Campieri; A Belluzzi; E Bertinelli; M Ferretti; C Brignola; Gilberto Poggioli; Mario Miglioli; L Barbara
Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches.
Digestive diseases and sciences 1994;39(7):1525-31.
1994: Paolo Gionchetti; Dino Vaira; Massimo Campieri; john holton; Marcello Menegatti; A Belluzzi; E Bertinelli; M Ferretti; C Brignola; Mario Miglioli
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients.
The American journal of gastroenterology 1994;89(6):883-7.
1994: A Lauri; Mario Miglioli; Gilberto Poggioli; L Barbara; Giulio Di Febo; Guido Biasco; Paolo Gionchetti; A Belluzzi; G Gozzetti
[Acute inflammation of ileal reservoir after restorative ileoanal anastomosis].
Minerva gastroenterologica e dietologica 1994;40(2):53-8.
1994: Paolo Gionchetti; Massimo Campieri; Carlo Guarnieri; A Belluzzi; C Brignola; E Bertinelli; M Ferretti; Mario Miglioli; L Barbara
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission.
Digestive diseases and sciences 1994;39(3):550-4.
1994: A Belluzzi; C Brignola; Massimo Campieri; Paolo Gionchetti; Fernando Rizzello; S Boschi; S Cunanne; Mario Miglioli; L Barbara
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long-chain fatty acid composition in patients with Crohn's disease.
Alimentary pharmacology & therapeutics 1994;8(1):127-30.
1993: A Belluzzi; M Campieri; C Brignola; Paolo Gionchetti; M Miglioli; L Barbara
Polyunsaturated fatty acid pattern and fish oil treatment in inflammatory bowel disease.
Gut 1993;34(9):1289-90.
1993: C Brignola; C Belloli; P Iannone; G De Simone; C Corbelli; M Levorato; V Arienti; L Boriani; Paolo Gionchetti; A Belluzzi
Comparison of scintigraphy with indium-111 leukocyte scan and ultrasonography in assessment of X-ray-demonstrated lesions of Crohn's disease.
Digestive diseases and sciences 1993;38(3):433-7.
1992: Massimo Campieri; C Corbelli; Paolo Gionchetti; C Brignola; A Belluzzi; Giulio Di Febo; P Zagni; Gabriele Brunetti; Mario Miglioli; L Barbara
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis.
Digestive diseases and sciences 1992;37(12):1890-7.
1992: Massimo Campieri; E Bertinelli; Paolo Gionchetti; A Belluzzi; Maria Paola Tampieri; C Brignola; Mario Miglioli; L Barbara
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis.
The Italian journal of gastroenterology 1992;24(9 Suppl 2):2-3.
1992: Paolo Gionchetti; Massimo Campieri; A Belluzzi; G M Paganelli; Maria Paola Tampieri; E Bertinelli; C Brignola; Gilberto Poggioli; Mario Miglioli; G Gozzetti
Macrophage subpopulations in pouchitis.
Gut 1992;33(7):1008.
1992: Luigi Bolondi; Stefano Gaiani; C Brignola; Massimo Campieri; A Rigamonti; Gianni Zironi; Paolo Gionchetti; C Belloli; Mario Miglioli; L Barbara
Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry.
Scandinavian journal of gastroenterology 1992;27(6):501-7.
1992: C Brignola; P Iannone; S Pasquali; Massimo Campieri; Paolo Gionchetti; A Belluzzi; O Basso; Mario Miglioli; L Barbara
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease.
Digestive diseases and sciences 1992;37(1):29-32.
1992: C Brignola; G De Simone; P Iannone; C Belloli; A Evangelisti; Massimo Campieri; A Belluzzi; Paolo Gionchetti; Maria Paola Tampieri; E Bertinelli
Influence of steroid treatment's duration in patients with active Crohn's disease.
Agents and actions 1992;Spec No():C90-2.
1992: Paolo Gionchetti; Massimo Campieri; A Belluzzi; Maria Paola Tampieri; E Bertinelli; C Brignola; M Ferretti; P Boni; P Iannone; Mario Miglioli
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).
Agents and actions 1992;Spec No():C50-2.
1991: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; Mario Miglioli; L Barbara
Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.
Gut 1991;32(8):929-31.
1991: Paolo Gionchetti; Massimo Campieri; A Belluzzi; P Boni; C Brignola; H Ferretti; P Iannone; Mario Miglioli; L Barbara
Interleukin 1 in ulcerative colitis.
Gut 1991;32(3):338.
1991: Paolo Gionchetti; Carlo Guarnieri; Massimo Campieri; A Belluzzi; C Brignola; P Iannone; Mario Miglioli; L Barbara
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation.
Digestive diseases and sciences 1991;36(2):174-8.
1990: Paolo Gionchetti; M Schiavina; Massimo Campieri; A Fabiani; B M Cornia; A Belluzzi; C Brignola; P Iannone; Mario Miglioli; L Barbara
Bronchopulmonary involvement in ulcerative colitis.
Journal of clinical gastroenterology 1990;12(6):647-50.
1990: Paolo Gionchetti; Carlo Guarnieri; Massimo Campieri; A Belluzzi; C Brignola; P Iannone; Mario Miglioli; L Barbara
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ)
Gut 1990;31(6):730-1.
1990: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; Gabriele Brunetti; Mario Miglioli; L Barbara
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial.
International journal of colorectal disease 1990;5(2):79-81.
1990: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; A Petronelli; Mario Miglioli; L Barbara
Role of rectal formulations: enemas.
Scandinavian journal of gastroenterology. Supplement 1990;172():63-5.
1990: Paolo Gionchetti; Massimo Campieri; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; Mario Miglioli; L Barbara
Pentasa in maintenance treatment of ulcerative colitis.
Gastroenterology 1990;98(1):251.
1989: C Brignola; P Iannone; S Pasquali; M Campieri; Paolo Gionchetti; A Belluzzi; C Corbelli; P Zagni; M Levorato; I Cappello
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1989;4(4):373-7.
1989: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; F Torresan; Maria Paola Tampieri; P Iannone; Mario Miglioli; L Barbara
5-Aminosalicylic acid suppositories in the management of ulcerative colitis.
Diseases of the colon and rectum 1989;32(5):398-9.
1988: Paolo Gionchetti; A Belluzzi; Massimo Campieri; F Torresan; G M Tabanelli; C Brignola; Mario Miglioli; L Barbara
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema.
Methods and findings in experimental and clinical pharmacology 1988;10(10):667-9.
1988: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; G M Tabanelli; F Forresan; Mario Miglioli; L Barbara
Sulphasalazine and new related compounds.
Tropical gastroenterology : official journal of the Digestive Diseases Foundation 1988;9(4):179-83.
1988: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; G M Tabanelli; Mario Miglioli; L Barbara
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?
Journal of clinical gastroenterology 1988;10(4):406-9.
1987: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Mario Migaldi; G M Tabanelli; G Bazzocchi; Mario Miglioli; L Barbara
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis.
Digestive diseases and sciences 1987;32(12 Suppl):67S-70S.
1986: Massimo Campieri; G A Lanfranchi; C Brignola; G Bazzocchi; Paolo Gionchetti; M R Minguzzi; I P Cappello; C Corbelli; S Boschi
Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis.
Diseases of the colon and rectum 1986;29(2):108-10.
1985: Piero Del Soldato; Massimo Campieri; C Brignola; G Bazzocchi; Paolo Gionchetti; G A Lanfranchi; M Tamba
A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals.
Gastroenterology 1985;89(5):1215-6.
1985: Massimo Campieri; G A Lanfranchi; C Brignola; G Bazzochi; Paolo Gionchetti; M R Minguzzi; F Adami
5-aminosalicylic acid for the treatment of inflammatory bowel diseases.
Gastroenterology 1985;89(3):701-3.
1985: Massimo Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; Paolo Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.
Gut 1985;26(4):400-5.